Compare THR & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | THR | BCRX |
|---|---|---|
| Founded | 1954 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.6B |
| IPO Year | 2011 | 1994 |
| Metric | THR | BCRX |
|---|---|---|
| Price | $38.20 | $7.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $20.08 |
| AVG Volume (30 Days) | 406.8K | ★ 4.0M |
| Earning Date | 02-05-2026 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.04 | N/A |
| EPS | ★ 1.75 | N/A |
| Revenue | $509,054,000.00 | ★ $599,816,000.00 |
| Revenue This Year | $4.87 | $40.20 |
| Revenue Next Year | $4.78 | $7.71 |
| P/E Ratio | $21.31 | ★ N/A |
| Revenue Growth | 3.08 | ★ 45.38 |
| 52 Week Low | $23.05 | $6.00 |
| 52 Week High | $41.20 | $11.31 |
| Indicator | THR | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 58.40 | 48.04 |
| Support Level | $37.27 | $7.11 |
| Resistance Level | $41.20 | $7.92 |
| Average True Range (ATR) | 1.66 | 0.36 |
| MACD | -0.24 | -0.03 |
| Stochastic Oscillator | 50.77 | 23.38 |
Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.